Cargando…

Health-related quality of life in patients with pulmonary arterial hypertension

BACKGROUND: Improved outcomes with expanding treatment options for patients with pulmonary arterial hypertension present the opportunity to consider additional end-points in approaching therapy, including factors that influence health-related quality of life. However, comparatively little is known a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taichman, Darren B, Shin, Jennifer, Hud, Laryssa, Archer-Chicko, Christine, Kaplan, Sandra, Sager, Jeffery S, Gallop, Robert, Christie, Jason, Hansen-Flaschen, John, Palevsky, Harold
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1208953/ https://www.ncbi.nlm.nih.gov/pubmed/16092961 http://dx.doi.org/10.1186/1465-9921-6-92

Ejemplares similares

Validation of a brief telephone battery for neurocognitive assessment of patients with pulmonary arterial hypertension
por: Taichman, Darren B, et al.
Publicado: (2005)

Symptom phenotypes in pulmonary arterial hypertension: The PAH “symptome”
por: Matura, Lea Ann, et al.
Publicado: (2022)

Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension
por: Kingman, Martha, et al.
Publicado: (2017)

Pulmonary Arterial Hypertension Emergency Complications and Evaluation: Practical Guide for the Advanced Practice Registered Nurses in the Emergency Department
por: Hohsfield, Robin, et al.
Publicado: (2018)

Systemic arterial properties in pulmonary hypertension
por: Goodman, Randi, et al.
Publicado: (2021)

Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension
por: Vahdatpour, Cyrus A., et al.
Publicado: (2020)

Pulmonary Arterial Hypertension
por: Michelakis, Evangelos D., et al.
Publicado: (2007)

Telemonitoring for Home-assisted Ventilation: A Narrative Review
por: Ackrivo, Jason, et al.
Publicado: (2021)

Advanced airway management and respiratory care in decompensated pulmonary hypertension
por: Vahdatpour, Cyrus A., et al.
Publicado: (2021)

Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus document
por: Rahaghi, Franck F., et al.
Publicado: (2017)

BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis
por: McCarthy, Breanne E., et al.
Publicado: (2022)

A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost
por: Channick, Richard N., et al.
Publicado: (2013)

Pathophysiology, incidence, management, and consequences of cardiac arrhythmia in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Cirulis, Meghan M., et al.
Publicado: (2019)

Left Main Coronary Artery Compression in Pulmonary Arterial Hypertension: Percutaneous Treatment to Improve Symptoms
por: Edginton, Stefan, et al.
Publicado: (2020)

Reply to Helgeson et al.: Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
por: LaPatra, Tess, et al.
Publicado: (2022)

Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension
por: Breault, Nolan M., et al.
Publicado: (2023)

Volume Management in Pulmonary Arterial Hypertension Patients: An Expert Pulmonary Hypertension Clinician Perspective
por: Hansen, Lillian, et al.
Publicado: (2018)

Carvedilol for Treatment of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
por: Thenappan, Thenappan, et al.
Publicado: (2021)

Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat
por: Rahaghi, Franck F., et al.
Publicado: (2022)

Epigenetic mechanisms of pulmonary hypertension
por: Kim, Gene H., et al.
Publicado: (2011)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension
por: Archer, Stephen L., et al.
Publicado: (2013)

Exertional dyspnoea in pulmonary arterial hypertension
por: Dumitrescu, Daniel, et al.
Publicado: (2017)

Evaluation of the Impact of an Echocardiographic Diagnosis of Pulmonary Hypertension on Patient Outcomes
por: Xiong, Ping Yu, et al.
Publicado: (2020)

The isobaric pulmonary arterial compliance in pulmonary hypertension
por: Chemla, Denis, et al.
Publicado: (2021)

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Corrigendum for health‐related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: And analysis from the Pulmonary Hypertension Association Registry
por: Minhas, J., et al.
Publicado: (2022)

Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry
por: DuBrock, Hilary M., et al.
Publicado: (2021)

Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again
por: Prins, Kurt W., et al.
Publicado: (2018)

Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)
por: Minhas, Jasleen, et al.
Publicado: (2021)

Impact of the COVID‐19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association Registry
por: Mayer, Megan, et al.
Publicado: (2023)

Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension
por: Prins, Kurt W., et al.
Publicado: (2020)

Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?
por: Vinnard, Christopher, et al.
Publicado: (2018)

Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Harzheim, Dominik, et al.
Publicado: (2013)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
por: Yeo, Jina, et al.
Publicado: (2022)

Sex and gender in pulmonary arterial hypertension
por: Cheron, Céline, et al.
Publicado: (2021)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

Pulmonary hypertension and pulmonary artery dissection
por: Corrêa, Ricardo de Amorim, et al.
Publicado: (2013)

BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
por: Spikes, Leslie A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_99srdvb63m98lc60bskforqeku